Author: Peralta-Garcia, Alejandro; Torrens-Fontanals, Mariona; Stepniewski, Tomasz Maciej; Grau-Expósito, Judit; Perea, David; Ayinampudi, Vikram; Waldhoer, Maria; Zimmermann, Mirjam; Buzón, Maria J.; Genescà , Meritxell; Selent, Jana
Title: Entrectinib - a SARS-CoV-2 inhibitor in Human Lung Tissue (HLT) cells Cord-id: b4i3sxlv Document date: 2021_9_7
ID: b4i3sxlv
Snippet: Since the start of the COVID-19 outbreak, pharmaceutical companies and research groups have focused on the development of vaccines and antiviral drugs against SARS-CoV-2. Here, we apply a drug repurposing strategy to identify potential drug candidates that are able to block the entrance of the virus into human cells. By combining virtual screening with in vitro pseudovirus assays and antiviral assays in Human Lung Tissue (HLT) cells, we identify entrectinib as a promising antiviral drug. We foun
Document: Since the start of the COVID-19 outbreak, pharmaceutical companies and research groups have focused on the development of vaccines and antiviral drugs against SARS-CoV-2. Here, we apply a drug repurposing strategy to identify potential drug candidates that are able to block the entrance of the virus into human cells. By combining virtual screening with in vitro pseudovirus assays and antiviral assays in Human Lung Tissue (HLT) cells, we identify entrectinib as a promising antiviral drug. We found that part of the antiviral action of entrectinib is mediated by a non-specific mechanism, likely occurring at the viral membrane level. Such a profile could provide entrectinib with protection against the development of drug resistance by emerging SARS-CoV-2 variants.
Search related documents:
Co phrase search for related documents- action antiviral mechanism and low concentration: 1
- action mechanism and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- action mechanism and low concentration: 1, 2, 3, 4
- luciferase signal and luminescence plate: 1
Co phrase search for related documents, hyperlinks ordered by date